# US 2024/0390446 A1 · Compositions and methods for treating or preventing inflammatory diseases including diabetes and thyroid diseases

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0390446 A1
- Document ID: US20240390446A1
- Status: Published application
- Kind: A1
- Application number: 18/694,656
- Filed: 2022-09-22
- Published: 2024-11-28
- Earliest claimed: 2021-09-23
- Inventors: Rachel ALKALAY
- Web page: https://patentgrep.com/patent/US20240390446A1

## CPC

- A61K 36/71: Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61K 31/05: Phenols {(cannabinoids A61K31/658)}
- A61K 36/185: Magnoliopsida (dicotyledons)
- A61K 36/22: Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
- A61K 36/258: Panax (ginseng)
- A61K 36/324: Boswellia, e.g. frankincense
- A61K 36/424: Gynostemma
- A61K 36/53: Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K 36/534: Mentha (mint)
- A61K 36/537: Salvia (sage)
- A61K 36/54: Lauraceae (Laurel family), e.g. cinnamon or sassafras
- A61K 36/738: Rosa (rose)
- A61K 36/82: Theaceae (Tea family), e.g. camellia
- A61K 36/85: Verbenaceae (Verbena family)
- A61K 36/899: Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K 36/9064: Amomum, e.g. round cardamom
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 3/04: Anorexiants; Antiobesity agents
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61P 5/00: Drugs for disorders of the endocrine system
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 31/14: for RNA viruses
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A method of preventing or treating an inflammatory disease and/or conditions associated with inflammation and/or biomarkers associated with inflammation in a subject in need thereof is provided. Also provided are pharmaceutical compositions, articles and foods for the treatment of an inflammatory disease using natural active compounds such as herb and flower extracts.

## Claims

### Claim at position 1

-49. (canceled)

### Claim 50

A method of treating an inflammatory disease or condition associated with inflammation in a subject in need thereof, the method comprising administering to the subject an effective amount of a pharmaceutical composition or food supplement comprising extracts of Nigella sativa, Thymus, Origanum and Rhus coriaria.

### Claim 51 (depends on 50)

The method of claim 50, wherein said pharmaceutical composition or food supplement comprises at least one of thymoquinone or an analog thereof, thymol or an analog thereof, carvacrol or an analog thereof, bromelain or an analog thereof, tryptophan or an analog thereof.

### Claim 52 (depends on 50)

The method of claim 50, wherein said inflammatory disease comprises an autoimmune disease.

### Claim 53 (depends on 50)

The method of claim 50, wherein said inflammatory disease comprises an acute inflammatory disease.

### Claim 54 (depends on 50)

The method of claim 50, wherein said inflammatory disease comprises Type I, Type II or gestational diabetes.

### Claim 55 (depends on 50)

The method of claim 50, wherein said inflammatory disease is selected from Hashimoto's disease, Grave's disease, Goiter disease, Thyroid Nodules disease, irritable bowel syndrome, Crohn's disease, colitis, gastritis, dyspepsia, of allergies, candidiasis, cold related disorders, cholesterol disorders, hair loss, depression, hormonal disorders, obesity and any combination thereof.

### Claim 56 (depends on 50)

The method of claim 50 wherein the pharmaceutical composition or food supplement further comprises “Beduin Tea” comprising Rose Leaves Micromeria fruticose, Salvia, cymbopgon (Citral,) Aloysia, verbena officinalis, Origanum majorana, and/or menthe.

### Claim 57 (depends on 50)

The method of claim 50 wherein the pharmaceutical composition or food supplement further comprises “Beduin Tea” comprising sage, cardamom, cinnamon, black tea, habuk, and/or Marmaya.

### Claim 58 (depends on 50)

The method of claim 50, wherein pharmaceutical composition or food supplement further comprises at least one of Sesamum indicum, Gynostemma pentaphyllum, Boswellia sacra and Panax ginseng.

### Claim 59

A method for treating gestational diabetes and lowering blood glucose levels in a patient, comprising administering 5 ml daily of Sesame oil of 100% w/v to said patient for first prescribed period of time; and co-administering 5 ml daily of said Sesame oil 100% w/v and 5 ml daily of Nigella Sativa oil of 100% w/v for second prescribed period of time.

### Claim 60 (depends on 59)

The method of claim 59, wherein said first prescribed period of time is four days, and said second prescribed period of time is 18 days.

### Claim 61

A pharmaceutical treatment regimen for reversing alopecia and/or weight loss in a patient, said regimen comprising administering to said patient 2-15, per day of a pharmaceutical composition or food supplement comprising extracts of Nigella sativa, Thymus, Origamim and Rhus coriaria for a prescribed period of between two and three months.

### Claim 62 (depends on 61)

The pharmaceutical treatment regimen according to claim 61, wherein said extract mixtures further comprise compounds selected from thymoquinone, thymol, carvacrol, bromelain and tryptophan or plant extract containing tryptophan and analogs thereof.

### Claim 63 (depends on 50)

The method according to claim 50, wherein said inflammation is triggered by said viral infection.

### Claim 64

A pharmaceutical composition or food supplement comprising extracts of Nigella sativa, Thymus, Origanum and Rhus.

### Claim 65 (depends on 64)

A method of reducing cholesterol which comprises administering to a patient in need thereof the pharmaceutical composition or food supplement of claim 64.

### Claim 66 (depends on 64)

A method of reducing blood glucose levels which comprises administering to a patient in need thereof the pharmaceutical composition or food supplement of claim 64.

### Claim 67 (depends on 64)

A method of modulating at least one of albumin, alkaline phosphatase calcium, iron, potassium and vitamin D in the blood which comprises administering to a patient in need thereof the pharmaceutical composition or food supplement of claim 64.

### Claim 68 (depends on 64)

A method of modulating C-reactive protein which comprises administering to a patient in need thereof the pharmaceutical composition or food supplement of claim 64.

### Claim 69 (depends on 64)

A method of modulating at least one of RBC Hematocrit; Hemoglobin and platelets which comprises administering to a patient in need thereof the pharmaceutical composition or food supplement of claim 64.

### Claim 70 (depends on 64)

The pharmaceutical composition of claim 64 further comprising at least one of mango plants or fruits; ginseng, pineapple fruit extracts, tryptophan, silybin, milk thistle extract, chamomile, anise, star anise, α-bisabol, linalool, an extract of lavender, an extract of bergamot, an extract of rosewood, an extract of basil, an extract of neroli oil, turmeric or extract thereof, mango ginger or an extract thereof and curcumin.
